z-logo
open-access-imgOpen Access
Medin aggregation causes cerebrovascular dysfunction in aging wild-type mice
Author(s) -
Karoline Degenhardt,
Jessica Wagner,
Angelos Skodras,
Michael Candlish,
Anna Julia Koppelmann,
Katleen Wild,
Rusheka Maxwell,
Carola Rotermund,
Felix von Zweydorf,
Christian Johannes Gloeckner,
Hannah A. Davies,
Jillian Madine,
Domenico Del Turco,
Regina Feederle,
Tammaryn Lashley,
Thomas Deller,
Philipp J. Kahle,
Jasmin K. Hefendehl,
Mathias Jucker,
Jonas J. Neher
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2011133117
Subject(s) - psychology , neuroscience , medicine , cardiology
Significance Vascular dysfunction, as it develops either during normal aging or vascular disease, remains a major medical problem. The amyloid Medin, which is derived from its precursor protein MFG-E8 (through unknown mechanisms), forms insoluble aggregates in the vasculature of virtually anybody over 50 years of age, and it has been hypothesized that Medin aggregation could contribute to age-associated vascular decline; however, mechanistic analyses have so far been lacking. Our data now demonstrate that reminiscent of humans, mice also develop Medin deposits in an age-dependent manner. Importantly, mice that genetically lack Medin show reduced vascular dysfunction in the aged brain. Therefore, the prevention of Medin accumulation should be investigated as a novel therapeutic approach to preserve vascular health in the aging population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom